CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
Vallos (DCP) +3 moredevice
Likely dose
Not stated in record
Key inclusion· 6
  • Single non-molar tooth requiring extraction with planned dental implant replacement
  • Adequate restorative space for dental implant-retained restoration
  • At least 10mm alveolar bone height without impingement on maxillary sinus or inferior alveolar canal
  • Buccal or lingual bony plate dehiscence no more than 50% of socket depth
Key exclusion· 7
  • Unwilling or unable to comply with follow-up schedule
  • Mentally incompetent, prisoner, or pregnant
  • Current smoker of >10 cigarettes per day
  • Active infection other than periodontitis

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05400213
NCT05400213N/ACompleted

Randomized Controlled Trial of Wound Healing Following Tooth Extraction and Ridge Preservation Using Decalcified Freeze-dried Bone Allograft (DFDBA) Alone in Particulate Fiber Form and in Combination With Xenograft

The University of Texas Health Science Center at San Antonio·interventional·Posted Jun 1, 2022·Updated Jun 19, 2025

In Brief

A clinical study evaluating Vallos (DCP), Vallomix (DCF), and 2 other interventions for Dental Extraction and Wound Heal. Completed, enrolled 102 participants across 1 site.

Detailed Summary

The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 1, 2022
Enrollment StartAug 2, 2022
Primary CompletionAug 23, 2024
Study CompletionDec 18, 2024
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 4.1 years ago

Interventions

Vallos (DCP)device

Demineralized freeze-dried bone allograft (DFBA) in a small particle form

Vallomix (DCF)device

A combination of cow-derived xenograft and human-derived DFDBA particulate

Vallos-F (DPX)device

Demineralized freeze-dried bone allograft (DFDBA) in a fiber form

Vallomix-F (DFX)device

A combination of cow-derived xenograft and human-derived DFDBA fibers